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Background and importance Healthcare personnel 
working in the emergency department (ED) is at risk of 
acquiring severe acute respiratory syndrome coronavirus-2 
(SARS-Cov-2). So far, it is unknown if the reported variety 
in infection rates among healthcare personnel is related to 
the use of personal protective equipment (PPE) or other 
factors.
Objective The aim of this study was to investigate the 
association between PPE use and SARS-CoV-2 infections 
among ED personnel in the Netherlands.
Design, setting and participants A nationwide 
survey, consisting of 42 questions about PPE-usage, ED 
layout - and workflow and SARS-CoV-2 infection rates of 
permanent ED staff, was sent to members of the Dutch 
Society of Emergency Physicians. Members were asked 
to fill out one survey on behalf of the ED of their hospital. 
The association between PPE use and the infection rate 
was investigated using univariable and multivariable 
regression analyses, adjusting for potential confounders.
Outcome measures Primary outcome was the 
incidence of confirmed SARS-CoV-2 infections among 
permanent ED staff between 1 March and 15 May 2020.
Results Surveys were sent to 64 EDs of which 45 
responded (70.3%). In total, 164 ED staff workers 
[5.1 (3.2–7.0)%] tested positive for COVID-19 during 
the study period compared to 0.087% of the general 
population. There was significant clustering of infected 
ED staff in some hospitals (range: 0–23 infection). In 13 
hospitals, an FFP2 (filtering facepiece particles >94% 
aerosol filtration) mask or equivalent and eye protection 
was worn for all contacts with patients with suspected 
or confirmed SARS-CoV-2 during the whole study 
period. The unadjusted staff infection rate was higher 
in these hospitals [7.3 (3.4–11.1) vs. 4.0 (1.9–6.1)%, 
absolute difference + 3.3%]. Hospital staff testing 
policy was identified as a potential confounder of the 
relation between PPE use and confirmed SARS-CoV-2 
infections (collinearity statistic 0.95). After adjusting for 
hospital testing policy, type of PPE was not associated 
with incidence of COVID 19 infections among ED staff 
(P = 0.40).
Conclusion In this cross-sectional study, the use of 
high-level PPE (FFP2 or equivalent and eye protection) 
by ED personnel during all contacts with patients with 
suspected or confirmed SARS-CoV-2 does not seem 
to be associated with a lower infection rate of ED staff 
compared to lower level PPE use. Attention should be 
paid to ED layout and social distancing to prevent cross-
contamination of ED personnel. European Journal of 
Emergency Medicine 28: 202–209 Copyright © 2020 The 
Author(s). Published by Wolters Kluwer Health, Inc.
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Introduction
Since the first cases of severe acute respiratory syndrome 
coronavirus-2 (SARS-CoV-2) were discovered in China, the 
virus has spread rapidly over the world, causing a global 
pandemic [1,2]. The clinical spectrum of SARS-CoV-2, 
ranges from asymptomatic infections to a systemic illness 
with severe pneumonia causing acute respiratory distress 
syndrome (ARDS). Droplet transmission through coughing 
and sneezing is the primary form of transmission, although 
transmission can also occur through direct and indirect 
contact with surfaces in the immediate vicinity of the 
infected person. Furthermore, airborne transmission may 
occur under specific circumstances in which procedures 
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or treatments generate aerosols [nebulization, bag-valve-
mask ventilation, noninvasive ventilation, cardiopulmonary 
resuscitation (CPR) and endotracheal intubation] [3–5].
Healthcare personnel working in emergency depart-
ments (EDs) or in the prehospital setting are at particular 
risk for SARS-CoV-2 transmission because the number of 
patient contacts on a daily basis is high, it is not always 
possible to obtain a reliable history and aerosol-generat-
ing procedures (AGPs) are performed regularly. Personal 
protective equipment (PPE) has, therefore, been consid-
ered of paramount importance to protect healthcare per-
sonnel [6].
On the basis of the mode of transmission, the WHO rec-
ommends droplet and contact precautions for healthcare 
personnel working with COVID-19 patients and airborne 
PPE precautions when AGPs are carried out [5]. At the 
same time, other organizations, including the US Centers 
for Disease Control (CDC) and the European Centre for 
Disease Prevention and Control (ECDC), recommend 
airborne precautions for all contact with patients with a 
(suspected) COVID-19 infection. However, the evidence 
underlying these recommendations is limited and largely 
translated from experiences with outbreaks of other viral 
infections, such as influenza [6,7].
Reported infection rates of healthcare personnel differ 
widely [8–11]. Whether this variety is caused by variation 
in prevalence of SARS-CoV-2, by exposure to AGP or by 
variety in PPE-usage (due to the variety in recommenda-
tions or shortage in PPE at the height of the pandemic), 
has never been reported.
Therefore, the aim of this study is to investigate the asso-
ciation between PPE use and SARS-CoV-2 infections 
among ED personnel in the Netherlands in a nationwide 
study.
Materials and methods
Study design and setting
We performed a nationwide cross-sectional study among 
permanent ED staff (doctors and nurses) working in EDs 
across the Netherlands at the time of the SARS-CoV-2 
pandemic, in order to investigate if the level of PPE used 
for aerosol- and nonaerosol generating procedures in the 
ED were associated with SARS-CoV-2 infections among 
healthcare personnel.
The Netherlands is a relatively small country (41.543 
km2), with 78 EDs serving a population of 17.4 million 
people 24/7. Hospitals are spread across the country, with 
most hospitals being situated in the west of the country 
where population density is highest. In most hospitals 
(n = 64), the ED has a permanent staff of both ED physi-
cians (consultants and residents) and ED nurses. Patients 
are seen both by ED physicians and by physicians and 
trainees from other specialties who work together with 
permanent personnel in most EDs [12].
Study period
The study period (1 March until 1 May) was chosen to 
include peak exposure for all hospitals across the coun-
try. The first case of SARS-CoV-2 in the Netherlands was 
reported on 27 February 2020 in the south of the country, 
after which SARS-CoV-2 spread rapidly, with relatively 
sparing of the northern regions [13]. Peak of the pandemic 
was encountered at the beginning of April with 1399 daily 
new cases, 611 hospitalizations and 175 COVID related 
fatalities, after which the curve flattened. The geograph-
ical distribution of COVID cases at the peak of the epi-
demic in the Netherlands is depicted in Fig. 1.
Study participants and data acquisition
An online survey was sent to all members of the Dutch 
Society of Emergency Physicians (DSEP). Members 
were asked to fill out a survey on behalf of the ED of 
the hospital where they practiced. The survey contained 
42 questions about the number of ED attendances dur-
ing the study period, the organization of care for patients 
with (suspected) SARS-CoV-2 provided in their EDs, the 
number of AGPs performed, SARS-CoV-2 testing policy 
of the hospital, PPE use and the number of suspected- 
and confirmed COVID-19 infections under healthcare 
personnel during the study period. Data about PPE use 
were requested for both the start- and end of the study 
period to account for changes in the PPE regime during 
the study period. Data were obtained both for patient 
contacts with and without AGPs.
SARS-CoV-2 infection rates of the general population in 
the catchment area of each hospital were obtained from 
the Dutch National Institute for Public Health and the 
Environment (Rijksinstituut voor Volksgezondheid en 
Milieu).
The study was regarded as exempt research by the medi-
cal ethical committee of the Medical Centre Leeuwarden 
(protocol number 1099).
Outcome
The primary outcome was the rate of confirmed SARS-
CoV-2 infections among permanent ED staff between 
1 March and 15 May 2020. The secondary outcome was 
the rate of confirmed and suspected SARS-CoV-2 infec-
tions among permanent ED staff between 1 March and 
15 May 2020. SARS-CoV-2 infections were regarded as 
confirmed when viral DNA was detected by reverse tran-
scriptase PCR (RT-PCR) in the nasopharynx swab.
To account for a maximum 14 day incubation time of SARS-
CoV-2, 15 May and not 1 May was chosen. Permanent staff 
was defined as ED physicians (consultants and residents) 
and nurses who were working in the ED only (and not 
in other hospital locations or healthcare facilities) during 
the study period. The study was limited to permanent 
personnel to make it possible to calculate infection rates 
more accurately and minimizes the chance that personnel 
acquired infections elsewhere in the hospital.
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Sample size calculation.
Based on an expected infection rate of at least 2% (on aver-
age 2% of the general population had SARS-CoV-2 anti-
bodies during the study period [14]), and the general rule 
of thumb that the sample size should be 10 times larger 
than the number of variables in the study, we estimated 
that 2000 fulltime equivalent (FTE) of ED staff would be 
needed to adjust the relation of PPE use with our primary 
endpoint for 4–6 potential confounders in regression anal-
ysis [15]. With an anticipated average ED workforce of 50 
FTE, we, therefore, aimed to recruit at least 40 EDs.
Data analysis
Descriptive statistics were represented as means (95% 
confidence interval) when normally distributed or 
median (IQR) when skewed. Categorical data were 
presented as number (n, %). PPE use in the ED during 
the study period was stratified according to the level of 
mucous membrane protection provided. The reference 
was EDs where FFP-2 (filtering facepiece particles >94% 
aerosol filtration) masks (or equivalent or higher level of 
protection masks) and eye protection were worn during 
all patient contacts (irrespective of AGP were performed) 
throughout the whole study period. Unadjusted SARS-
CoV-2 infection rates of personnel working in these EDs 
were compared to infection rates in other EDs by the chi-
square test. Infection rates between various types of ED 
staff members (physicians, residents and nurses) were 
compared with analysis of variance with post hoc Tukey. 
Univariate correlation analysis was performed to investi-
gate the effect of potential confounders on the relation 
between PPE use and SARS-CoV-2 infection rates.
Potential confounders considered were: the SARS-CoV-2 
prevalence in the catchment area of the hospital (both 
cases and hospitalizations/100 000 subjects), the esti-
mated number of patient contacts- and AGP per FTE 
ED personnel during the study period, organization of 
SARS-CoV-2 patient triage and care (triage before- or 
in ED), dedicated SARS-CoV-2 rooms (y/n), availability 
Fig 1.
Geographical distribution of COVID cases at the peak of the first wave of the epidemic in the Netherland.
Copyright © 2021 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
The influence of PPE on SARS-Cov-2 infection rates of ED personnel Schmitz et al. 205
of isolation room (y/n), reuse of PPE (y/n) and hospital 
testing policy for healthcare personnel [(was all ED per-
sonnel with complaints that could possibly be related to 
COVID tested (y/n)]. As testing policy changed in many 
institutions during the study period, a factor (between 0 
and 1) was created as a proxy for testing policy, account-
ing for the date of policy change, wherein one was equiv-
alent to 100% of the time testing all ED personnel with 
complaints.
Multivariable linear regression analysis was performed to 
investigate the association of PPE use and infection rate 
of ED personnel. All potential confounders significantly 
(P < 0.1) related to the SARS-CoV-2 infection rate in 
univariate analysis were included in the final regression 
model (forward entry). Missing data are reported accord-
ing to the Strengthning the Reporting of Observational 
studies in Epidemiology guidelines [16].
All analyses were performed using, SPSS version 26.0 
(SPSS inc.,Chicago, USA).
Results
Study population and logistics of COVID-19 care
Surveys were sent to all DSEP-members, representing 
64 of the 78 different ED’s across the country. In total, 
45 surveys were returned (response rate 70.3%) of which 
24 had filled out all 42 questions, and 21 had one or more 
missing data. The primary endpoint (SARS-CoV-2 infec-
tion rate of permanent ED personnel) was available for 
43 ED (infection rates for ED nurses were not reported 
in two hospitals) and these were included for further 
analysis. Participating ED were spread across the country 
(7 in the northern provinces, 17 in the west, 8 in the south 
and 11 in the east). Table 1 depicts the characteristics of 
these 43 departments.
Triage of patients with a (suspicion of) a SARS-CoV-2 
infection was performed outside the ED (n = 18) or in the 
ED (n = 25). Most EDs (n = 39, 90.7%) had dedicated areas 
or rooms where patients suspected of a SARS-CoV-2 infec-
tion were seen, either of fixed- (n = 14) or flexible (n = 25) 
size. Only a minority (n = 7, 16.3%) of the EDs had the 
capacity to treat all these patients in a sluice room. In all 
participating hospitals, ED physicians (consultants and 
registrars) and ED nurses were directly involved in the tri-
age and primary care for SARS-CoV-2 patients, including 
AGP’s such as CPR (88.4%) and initiation of noninvasive 
ventilation (44.2%). During the COVID-19 pandemic, 
endotracheal intubation in the ED was performed by anes-
thesiologists in the majority of the hospitals (n = 39, 90.7%).
At the start of the study period, as per protocol in 20 hos-
pitals (46.5%), ED personnel with health complaints that 
could possibly be related to SARS-CoV-2 infection were 
immediately tested for SARS-CoV-2 with a nasopharynx 
swab. At the end of the study period, this was standard 
policy in 38 hospitals (88.4%).
Basic hand hygiene was practiced in all 43 hospitals, 
and a protective base layer (n = 43, 100%), a fluid repel-
lant overcoat (n = 42, 98%), gloves (n = 42, 98%) and eye 
protection (n = 39 (91%) for non-AGP contacts and n = 41 
(95%) for AGP contacts were worn in most EDs at the 
start of the study period. A hood was worn in about half 
of the hospitals. For non-AGP patient contacts, consid-
erable variation was present in the type of face masks 
used (Table 2). For AGP, FFP2 or equivalent level face 
masks were worn in all but three hospitals for AGP, and 
in all but two hospitals, eye protection was worn, with 
additional face protection in the form of a welding mask 
in 13 hospitals. In between the start- and end of the study 
period, PPE-policy for non-AGP changed in 27/43 hospi-
tals, with more hospitals starting to use lower-level FFP 
face masks for non-AGP patient contacts. At the same 
time, eye protection (glasses or goggles) use and the use 
of fluid repellant overcoats increased. PPE use for AGP 
remained unchanged in the vast majority of hospitals 
(Table 2). Shortage of PPE was reported by two hospitals 
during the study period. FFP masks were sterilized and 
re-used in 17 hospitals (39.5%) during the study period 
and 18 hospitals (41.8%) reported the (temporarily) use 
of PPE from nonregular providers.
In 13 hospitals, representing 41  938 (32.8 %) of the 
patient contacts and 944 (30.8%) ED staff members, 
FFP-2 masks (or equivalent) and eye protection were 
worn during all patient contacts (irrespective of AGP) 
throughout the whole study period. This ‘high level of 
protection’ group was used as a reference group in sub-
sequent analysis. The use of other PPE (baselayer, over-
coat, gloves and hood) was not different in these hospitals 
compared to other hospitals.
Unadjusted SARS-CoV-2 infection rates
During the study period, 164 ED staff members from 
one of the 43 participating EDs were tested positive 
for SARS-CoV-2 (16 consultants, 27 residents and 121 
nurses). The number of infected ED staff members per 
hospital ranged from 0 to 23 (corresponding to 0 and 
Table 1  Hospital characteristics of participating hospitals
 Total Median (IQR) per hospital
Hospital characteristics   
 Urban hospital (n) 




 Yearly ED census (n) 114.3642 25.500 (16.000–31.359)
 EM physicians (FTE) 354.5 8.2 (4.5–11.2)
 EM residents (FTE) 384.0 8.2 (6.0–11.8)
 ED nurses (FTE) 1546.7 34.3 (25.0–45.8)
ED characteristics during study period   
 ED attendances (n) 125.728 2852 (1882–3798)
 ED procedures (n)   
  CPR 399 7 (2–13)
  RSI 218 4 (0–7)
CPR, cardiopulmonary resuscitation; ED, emergency department; FTE, fulltime 
equivalent; IQR, interquartile range; RSI, rapid sequence intubation.
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31.1% of the ED workforce). The majority of the partic-
ipating hospitals had 1–9 infected staff members, nine 
hospitals had no infected personnel, whereas four hos-
pitals had >10 infected staff members. In 69 staff mem-
bers, SARS-CoV-2 was suspected on any time during the 
study period, but not confirmed by testing. Table 3 shows 
the number- and profession of ED staff who tested pos-
itive for- or were suspected of SARS-CoV-2 during the 
study period, stratified by the PPE-use group. In hospi-
tals where FFP-2 masks AND eye protection were worn 
during all patient contacts throughout the whole study 
period, 7.3 (3.4–11.1) % of personnel met the prespeci-
fied primary outcome (confirmed SARS-CoV-2 infection 
during the study period), compared to 4.0 (1.9–6.1)% in 
other hospitals (absolute difference + 3.3%, P < 0.001). 
For suspected infections these percentages were 0.9 
(0.0–2.2)% and 2.4 (0.8–4.1)%, respectively (absolute 
difference −1.5% P < 0.001). The infection rate was not 
significantly different between nurses, residents and con-
sultants (P = 0.25). Of the nine hospitals with no infected 
ED personnel, two used high level of protection PPE 
throughout the study period for all patient contacts.
Adjusted SARS-CoV-2 infection rates
Univariate correlation analysis was carried out to inves-
tigate which variables potentially confounded the rela-
tion between PPE use and SARS-CoV-2 infection rate 
during the study. Results are represented in Table  4. 
Hospital staff testing policy was identified as a poten-
tial confounder of the relation between PPE use and 
the primary outcome (confirmed SARS-CoV-2 infections 
among ED staff) in the study period (r = −0.35, P = 0.021). 
Interestingly, SARS-CoV-2 population prevalence in the 
catchment area of the hospitals (r = 0.17, P = 0.28) and 
ED-logistics of care and ED-layout variables were not 
associated with the number of confirmed- (or suspected) 
infections of ED personnel.
Multivariable analysis with forward entering of varia-
bles was carried out to explore if the hospital staff test-
ing policy was a confounder of the relation between the 
level of PPE used and the primary outcome. In the final 
model, containing these two variables, PPE use was no 
longer associated with the primary endpoint (R2 = 0.039, 
P = 0.40) as a more active staff testing policy was present 
in the hospitals where a higher level of PPE was used, 
resulting in more confirmed SARS-Cov-2 staff infections 
(collinearity statistic 0.95).
Discussion
In this nationwide cross-sectional study of permanent 
ED personnel working in EDs across the Netherlands, 
we found that the consequent use of high-level PPE 
(FFP2 mask or equivalent and eye protection) by ED 
personnel during all contacts with patients with- or sus-
pected of SARS-CoV-2 was not associated with a lower 
infection rate among ED personnel compared to when 
a lower level of PPE [FFP1(filtering facepiece particles 
>80% aerosol filtration) or surgical mask] was used.
PPE use for SARS-CoV-2 patients has been a topic of 
much debate over the past few months, especially for 
patients in whom AGP are not performed. The WHO 
advises the use of surgical masks when no AGP is per-
formed, whereas the ECDC advises to wear FFP2/N95 
(>95% aerosol filtration) respirators at any time when 
working with COVID-19 suspected or proven patients 
[5,17,18]. Most of the recommendations are based on 
limited evidence, and often extrapolated from studies on 
other respiratory viruses, such as influenza [7]. A recent 
meta-analysis on the effectiveness of N95 respirators 
Table 2 Personal protective equipment use as per 1 March 2020 
and 1 May 2020 for ED staff in Dutch hospitals (n = 43)
Non-AGP
PPE 1 March 
n (%) PPE 1 May 
Base layer White jacket + trousers 37 (86) 37 (86%)
Scrub suit 2 (5) 2 (5%)
White jacket + trousers  
OR scrub suit
4 (9) 4 (9%)
Gloves Single 41 (95) 41 (95%)
Double 1 (2) 2 (5%)
None 1 (2) 0
Overcoat Overcoat with long sleeves 36 (84) 38 (88%)
Plastic apron 3 (7) 1 (2%)
Overcoat and apron 3 (7) 3 (7%)
None 1 (2) 1 (2%)
Surgical hat Surgical hat or orthopedic 
hoody
23 (53) 19 (44%)
None 20 (47) 24 (66%)
Eye protection Splash goggles/fire gog-
gles/splash shield/similar 
alternative
39 (91) 42 (98%)
None 4 (9) 1 (2%)
Face mask Surgical face mask or FFP1 11 (26) 26 (60%)
FFP2 or N95 29 (67) 16 (37%)
Surgical face mask/FFP1 
OR FFP2/N95
2 (5) 1 (2%)
None 1 (2) 0
AGP   
Base layer White jacket and trousers 37 (86) 37 (86%)
Scrub suit 3 (7) 4 (9%)
White jacket+ trousers  
OR scrub suit
3 (7) 2 (5%)
Gloves Single 39 (91) 37 (86%)
Double 4 (9) 6 (14%)
None 0 0
Overcoat Overcoat with long sleeves 38 (88) 38 (88%)
Plastic apron 0 0
Overcoat and apron 4 (9) 5 (12%)
None 1 (2) 0
Surgical hat Surgical hat or orthopedic 
hoody
28 (65) 28 (65%)
None 15 (35) 15 (35%)
Eye protection Splash goggles/fire gog-
gles/splash shield/similar 
alternative
41 (95) 43 (100%)
none 2 (5) 0
Face mask Surgical face mask or FFP1 1 (2) 1 (2%)
FFP2 or N95 40 (93) 41 (95%)
Surgical face mask/FFP1 
OR FFP2/N95
1 (2) 1 (2%)
None 1 (2) 0
Additional PPE Welding screen 13 (30) 15 (35%)
AGP, aerosol generating procedures; FFP1, filtering facepiece particles >80% 
aerosol filtration; FFP2, filtering facepiece particles >94% aerosol filtration; N95: 
>95% aerosol filtration; PPE, personal protective equipment.
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versus surgical masks against influenza could not demon-
strate a difference between these two [19]. Our findings 
are in line with this. When adjusted for the hospital staff 
testing policy (as more liberal testing will result in more 
confirmed cases), the PPE regime was not a predictor of 
SARS-CoV-2 infections. In line with this, the combined 
number of confirmed and suspected ED staff infections 
was not significantly different between hospitals in 
which high-level PPE was used for all patient contacts 
compared to the other hospitals. Thereby our study sup-
ports current WHO SARS-CoV-2 PPE recommendations 
and contributes to the cost-effective use of PPE [5].
The overall infection rate of ED personnel in our study 
was 5.4%. This was much higher than the population 
prevalence in the general population during the study 
period (0.087%) but comparable to previous reports on 
SARS-CoV-2 infection rates of healthcare personnel [8–
10]. The high infection rate may be explained by various 
factors. First, the number of patient contacts in the ED 
is high, and for many presenting patients, it is unclear 
if they have SARS-CoV-2, as a significant proportion of 
patients is asymptomatic. Second, the ED is a depart-
ment where many AGPs are performed, which increases 
the risk of aerosol spread. Finally, ED layout and work 
conditions may play a role. Whereas the majority of the 
participating hospitals in our study had 1–9 infected staff 
members, four hospitals had >10 infected staff members. 
Staff-to-staff transmission between (asymptomatic) per-
sonnel may have occurred in these hospitals, emphasizing 
the importance of social distancing and other preventive 
measures on the workfloor as well. The clustering of 
Table 3 Unadjusted severe acute respiratory syndrome coronavirus-2 infection rates among ED healthcare personnel, stratified by per-




High level of protection hospitals 
(n = 13)
Other hospitals 
(n = 30) Missing P value
All personnel      
 ED staff members (n) 3064 944 2099 2  
 Confirmed SARS-CoV-2-  
 Infections [% (95% CI)]
164 [5.1 (3.2–7.0)] 73 [7.3 (3.4–11.1)] 91 [4.0 (1.9–6.1)] 2 <0.001**
 Suspected (but not confirmed)  
 SARS-CoV-2- Infections  
 [% (95% CI)]
69 [2.2 (0.8–3.0)] 8 [0.9 (0.0–2.2)] 61 [2.4 (0.8–4.1)] 3 <0.001**
 Suspected + Confirmed SARS-  
 CoV-2 infections [% (95% CI)]
233 [7.0 (5.0–9.1)] 81 [8.2 (4.5–11.9)] 152 [6.4 (3.9–9.1)] 4 0.23
ED consultants      
 Total number of consultants 459 121 338   
 Confirmed SARS-CoV-2-  
 infections (n)
16 3 13  0.98**
ED residents      
 Total number of residents 431 123 308   
 Confirmed SARS-CoV-2-  
 infections (n)
27 14 13  0.021**
ED nurses      
 Total number of nurses 2153 700 1453   
 Confirmed SARS-CoV-2  
 infections (n)
121 56 65  <0.001
CI, confidence interval; ED, emergency department; SARS-CoV-2, severe acute respiratory syndrome corona virus 2.
Table 4 Univariate Spearmann correlation coefficients of variables potentially associated with severe acute respiratory syndrome corona 
virus 2 infection rate of ED staff
 Confirmed SARS-CoV-2 
(n = 164)
Confirmed or suspected 
SARS-CoV-2 (n = 233)
 r P value r P value
High-level PPE throughout study period 0.32 0.036 0.16 0.32
Potential confounders  
 SARS-CoV-2 cases/100 000 in catchment area of hospitala 0.17 0.28 0.17 0.27
 SARS-CoV-2 hospitalizations/100 000 in catchment area of hospitala 0.07 0.66 0.16 0.31
 Patient contacts/FTE ED personnel 0.14 0.39 −0.06 0.71
 AGP/FTE ED personnel 0.004 0.98 0.23 0.19
 Dedicated rooms in (separate area of) ED for SARS-CoV-2 patients −0.02 0.88 0.09 0.55
 Triage outside ED (y/n) −0.04 0.79 0.05 0.77
 Isolation room (y/n) −0.18 0.24 −0.12 0.46
 Re-use of PPE (y/n) 0.04 0.80 0.13 0.42
 Hospital staff testing policy (% of study period in which all symptomatic personnel was  
immediately tested)
−0.35 0.021 −0.087 0.58
AGP, aerosol generating procedures; ED, emergency department; FTE, fulltime equivalent; PPE, personal protective equipment; SARS-CoV-2, severe acute respiratory 
syndrome corona virus 2.
aCases/100 00 and hospitalizations/100 000 in catchment area were measured on 6 May , halfway the study period. . .
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infections in some hospitals could not be explained by 
the shortage of PPE. Although reported by a few hospi-
tals, these were not the hospitals with high staff infec-
tion rates. Due to shortage, face masks were sterilized 
and re-used in a few hospitals during the study period. 
However, recent literature has confirmed the safety of 
this procedure [20]. Besides hospital factors, community 
factors may influence the SARS-CoV-2 ED personnel 
infection rate as well: when the SARS-CoV-2 prevalence 
is higher in the catchment area of the hospital (where 
most personnel live), their theoretical chance of acquir-
ing SARS-CoV-2 outside the hospital is higher as well. 
Interestingly, we could not demonstrate such a relation, 
despite considerable variation in the number of infected- 
or hospitalized patients/100 000 (from 61 to 316) in the 
various hospital catchment areas.
In this study, we gathered information regarding various 
potential confounders of the relation between PPE use 
and our primary endpoint (confirmed ED staff infection 
rate), including the SARS-CoV-2 population prevalence 
in the catchment area of the hospital, the number of 
patient contacts and AGP’s performed during the study 
period and parameters regarding the organization of 
SARS-CoV-2 care and physical layout of the ED. None of 
these parameters was significantly associated with our pri-
mary endpoint, although it should be mentioned that our 
study was not powered to detect significant associations 
of these potential confounders. As both PPE regime and 
none of the potential confounders was significantly cor-
related to personnel infection rates, we hypothesize that 
other (unmeasured) factors, such as the previously men-
tioned staff-to-staff transmission play an important role.
Limitations
This study had several limitations, most inherent to the 
retrospective design. First, we were reliant on reliable 
data registration and data-completeness. As mentioned, 
we were unable to identify all AGP performed during the 
study period and could not calculate infection rates for 
two hospitals as the total number of staff was not pro-
vided. Furthermore, the level of detail regarding the 
organization of SARS-CoV-2 care and physical layout of 
the ED was limited, as for example, no information was 
obtained regarding sessional/nonsessional use of PPE, 
and information regarding floor space and the number of 
staff working simultaneously was lacking. Furthermore, 
although we knew the number of patients hospitalized 
per 100  000 inhabitants for each hospital catchment 
area, it was unknown how many patients with confirmed 
SARS-CoV-2 were actually seen in each department 
during the study period. Further, we cannot completely 
exclude that the absence of an association between PPE 
regime and our primary endpoint could be attributed to 
a type II statistical error, although we render this highly 
unlikely as the event incidence rate (ED personnel 
tested positive) was much higher than 2% we anticipated 
in our power calculation. Finally, we may potentially have 
missed ED personnel who had a false negative RT-PCR 
for SARS-Cov-2 (as sensitivity is reported to be 71–98% 
[21]) or who tested positive for SARS-CoV-2 when they 
were tested outside the hospital where they practiced.
Conclusion
In this cross-sectional study, the use of high-level PPE 
(FFP2 or equivalent and eye protection) by ED person-
nel during all contacts with patients with suspected or 
confirmed SARS-CoV-2 does not seem to be associated 
with a lower infection rate of ED staff compared to low-
er-level PPE use. Attention should be paid to ED layout 
and social distancing measures on the work floor in order 
to prevent cross-contamination.
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